BackTable / Urology / Article
BPH Patient Education: Focus on Shared Treatment Decisions
Kaitlin Sheppard • Updated Dec 4, 2024 • 34 hits
Benign prostatic hyperplasia (BPH) care is shifting away from long-term polypharmacy symptom management and towards patient-centered surgical approaches. This shift in practice is driven in large part by the recognition that bladder health continues to decline when the mechanical source of BPH symptoms is not addressed. How do we best educate our patients on the long-term consequences of insufficient BPH treatment? And how do we enable our patients to decide which treatment is most appropriate for their individual circumstances?
The ManVsProstate initiative, founded by Dr. Wayne Kuang, provides a series of tools, educational resources, and personalized strategies to empower patients and clinicians to better manage BPH. Dr. Kuang previews some of the ManVsProstate fundamentals in this article, focusing on how to educate patients on bladder health and the various BPH treatment modalities. This article features excerpts from the BackTable Urology Podcast. You can listen to the full podcast below.
The BackTable Urology Brief
• The ManVsProstate framework classifies BPH procedures into four categories: least invasive surgical therapy (LIST), minimally invasive surgical therapy (MIST), invasive surgical therapy (IST), and most invasive surgical therapy (MOST). Each category balances factors like invasiveness, patient risk, and the clinical setting, providing a framework for individualized treatment planning.
• Surgical techniques such as UroLift, REZUM, Aquablation and iTind are selected based on the patient's specific prostate anatomy, offering targeted solutions to address obstruction.
• To engage BPH patients in their care, Dr. Kuang routinely explains the mechanical nature of BPH and its potential to progress without intervention. Clinicians can guide patients to understand the importance of proactive BPH treatment and bladder health preservation.
• The ManVsProstate movement advocates for reframing BPH management as a multidisciplinary effort, involving not just urologists but also nephrologists, primary care physicians, and general surgeons.
Table of Contents
(1) Engaging BPH Patients Through Personalized Tools & Educational Resources
(2) Which BPH Procedure? A Patient-Centered Framework
(3) Rethinking Prostate Care: The ManVsProstate Initiative
Engaging BPH Patients Through Personalized Tools & Educational Resources
Managing benign prostatic hyperplasia (BPH) effectively requires a comprehensive approach that integrates patient education, diagnostic precision, and tailored treatment strategies. Visual aids, such as bladder health diagrams, are instrumental in helping patients understand how untreated BPH can progress, emphasizing the need for timely intervention. These tools not only address gaps in primary care assessments but also frame BPH as a mechanical condition requiring mechanical solutions, beyond the temporary relief provided by medications.
To strengthen patient engagement, resources like the IPSS score offer a clear, data-driven way to highlight the severity of symptoms and guide conversations about next steps. Advanced decision-making tools, such as bphtool.com, enhance this process by providing personalized predictions about treatment outcomes, including symptom improvement and risk reduction for acute urinary retention. These insights empower both patients and clinicians to make informed choices that align with individual needs.
The integration of surgical planning frameworks further refines care, allowing providers to select interventions that account for prostate size, shape, and detrusor function. Procedures such as UroLift, REZUM, and iTind exemplify how anatomical considerations can inform treatment selection, offering minimally invasive options that address specific structural challenges. By weaving these resources and strategies into practice, clinicians can not only improve outcomes but also adapt effectively to advancements in technology and patient expectations.
[Dr. Jose Silva]:
You mentioned resources and getting help from the industry. In my office, in every room, I have the diagram from UroLift about the different stages of bladder health, or at least the picture, which I showed the patient, "Hey, this is what we're trying to prevent. Once it's at the end, that's it." Most patients, "But I was never told this. I was told the PCP says that everything was fine."
…
[Dr. Wayne Kuang]:
The resources are critical. The number one resource is our minds. We have to come in to recognizing this is a mechanical problem, that this is a mechanical solution. Medications are part of the equation, but they are temporizing measures, and that we are going to be their guide, and we're going to get them the data. Number two, very simple, our eyeballs and our hands. When you look your patient in the eye, you hold up their IPSS with their handwritten IPSS score and their signature in the bottom, and you say, "Hey, Mr. Smith, this is a problem." That is a huge resource. That is a huge igniter.
When they hear it from someone they trust, "Oh my gosh, that's a problem?" "That's not fine, Mr. Smith." Right there. That takes care of that whole problem you talked about. Then our hands. I use a lot of gesticulation showing the prostate as a mini donut getting tighter, the bladder squeezing like an octopus. The reason why I bring it up is we have it all right here. Yes, those resources like the pictures of trabeculations help, but you don't have to always rely on those. If you guys do have that trabeculation photographs showing the progression from a normal bladder to a severely trabeculated bladder with cellulose, that is fantastic.
Quick tip, get two of them, one in the patient consultation room, get another one, put it on a foam board, attach it to the wall right next to the cysto, or hanging off the side of your cysto monitor so you can show exactly what their bladder looks like versus the one that you already taught them about in the pre-cysto counseling. The other resources out there, for example, ManVsProstate, we're trying to create flow charts, report cards, list of surgical categories, decision making aids for patients that should be coming out this spring, as well as flow charts for each types of practices depending on what you have, whether you have Cystotrust Uroflow, Cystotrust Urodynamics, Cystotrust Urocuff.
There's not one way to skim the cat. As long as you're presenting all the data about detrusor function, prostate size, prostate shape, and talking about the five stages of bladder health in however you want to do it, that could be very helpful. Then there are more formal avenues for resources. One that just came out is called bphtool.com. Based on a lot of data, especially the COMBAT trial, it lets you look at if you put someone in medications, Tamsulosin, Dutasteride, combination therapy, what can you expect their IPSS score to improve by, as well as what is the potential risk for acute urinary retention episode over the next four years?
Wow, now we have a tool. For medical legal, they say it's not a clinical tool, but take it for what it is. Now you have something to say, "Hey, look, Mr. Smith, that's your risk. We don't want that risk. Our goal is to keep you out of stage three, four, and five. This is something we need to think about." Other resources out there, just a big shout out to the Canadians. They have the decision-making tool for choosing types of surgeries, de-obstructing technologies that might best fit a certain patient for his prostate. That's also another great tool and resource.
[Dr. Wayne Kuang]:
How do they come up with that, choosing which technique is better? It's just based on the size of the prostate, based on the length. What are they using to–
[Dr. Jose Silva]:
Predominantly size, but it's something definitely to check out and see if you can incorporate it. I don't think it has all of the technologies, because as you and I both know, the technology are changing very rapidly. ManVsProstate is really working now to look at, how do we now personalize the therapy? What do by that? If we look at UroLift, it really is focusing on the roof and laterally. Many people have had issues as I coached folks up on the floor, that high bladder neck, moderate bladder neck. The way we solve that with UroLift, so you braise the roof, create an anterior box.
Then REZUM is a little bit different. It's working more laterally, not so much anteriorly, and it's a little bit on the floor. Then now we have iTind, for example, in the category of list, which is bringing in a combination of the roof at a twelve o'clock time, five and seven o'clocks, creating a relaxing incisions like a twip, allowing the lateral walls to relax away to the sides and dropping the bladder neck. Now, can we define that further, choosing surgical technologies based on the specific anatomy? I think we're going to get there. Then you have invasive surgical therapies in the category of IST and MOST, which is really a circumferential therapy. Looking at the surgical categories way past just size as a criteria, but really looking at shape and then bladder function.
Listen to the Full Podcast
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Which BPH Procedure? A Patient-Centered Framework
Effective management of benign prostatic hyperplasia (BPH) hinges on aligning procedural approaches with patient-specific factors and the clinician’s expertise. The ManVsProstate framework of least invasive surgical therapy (LIST), minimally invasive surgical therapy (MIST), invasive surgical therapy (IST), and most invasive surgical therapy (MOST) provides a structured way to categorize interventions based on invasiveness, risk, and setting. This classification not only guides patient education but also enables individualized treatment decisions by balancing durability, cost, and patient vitality.
[Dr. Jose Silva]:
Can you go in and tell us more or less your algorithm in terms of deciding more or less what was the best procedure for each patient?
[Dr. Wayne Kuang]:
In ManVsProstate, do what you do well and do a lot of it, saving as many bladders of the now and of the future. What I tell people, we're all different. If we were all the same, we'd just all do the same fellowship, right? There are folks who are ablative, extirpative. There's people who are reconstructive, and different technologies will appeal to different urologists. That's why we came up with those four categories, least invasive surgical therapy, minimally invasive surgical therapy, invasive surgical therapy, and most invasive surgical therapy. Have an action plan or an offering for each of those categories so you can meet the men where they are. Once again, we're just guiding them. I hope that helps. Obviously, do what you do well because there's so many good options.
[Dr. Jose Silva]:
I just started doing the Aquablation and I really enjoy it. I started doing it like three months ago and I'll probably stick to it. I was doing a lot of Greenlight before that. Now I'm doing more Aquablation. I think based on the ultrasound guide, I see the big hole there.
[Dr. Wayne Kuang]:
Some of those images are really impressive. That's a very interesting topic, which is when we talk about technologies, and you may have or may not have seen that I created the four elements of efficiency for the BPO care pathway. One is treatment durability, a man's vitality that we need to honor and respect and optimize and preserve. We're trying to de-obstruct for the right prostate, the right patient within the window of curability. That's number three. The last is economic sustainability. I don't know with the data out there, but when we look at great technologies like Aquablation, does that mean replace the technology in every hospital? Is that sustainable economically? I don't know.
I do know we have a severe backlog throughout the world. In Sweden, they've had a huge rise in retention, stage four. UK as well. We're about to be hit by that here. We're already being hit by that. If we talk to urologists around the country, everyone's hearing about guys going in retention. Catheter rates for self-catheter going up. When we look at all these technologies, how do we find that right blend of economic sustainability, treatment durability, man's vitality and the window of curability? That's going to be an interesting part for Aquablation specifically as we move forward.
[Dr. Jose Silva]:
Are you doing any office-based procedures with BPH right now?
[Dr. Wayne Kuang]:
I do iTind. For me, that's been a great option. For my situation, which may not be for others, I think once again, just have as many tools in your tool belt in each of those surgical categories. Like I talked about before, I like how it's actually treating all four areas, interiorly, the roof, the floor, that bladder neck, bringing that down and allowing the lateral walls to relax to the side. Every surgeon, every practice is different. Make sure you have something for LIST, MIST, IST, and MOST.
[Dr. Jose Silva]:
Yes, good to know. Last week, we just got approved to start doing the iTind. I'm going to add that to my algorithm.
[Dr. Wayne Kuang]:
Because every guy's different. There are guys-- When we talk about LIST as a category that's non-permanent technologies done in the office with minimal risk, MIST is going to be permanent technologies done in the office with low risk. The invasive surgical therapies or IST is going to be permanent technologies done in the hospital with medium risk. Then you have MOST, which is going to be permanent technologies done in the hospital with high risk. That's at least how I use it as a patient education tool. Obviously, there are unique variants from each surgeon that can minimize risk in each of those categories, but it just is a general guideline.
Rethinking Prostate Care: The ManVsProstate Initiative
Advancing benign prostatic hyperplasia (BPH) care requires more than clinical expertise—it demands an empathetic, patient-centered approach that prioritizes bladder health and empowers patients to take ownership of their journey. Advocacy platforms like ManVsProstate provide resources for both patients and physicians, including educational videos, insights on the five stages of bladder health, and tools to address polypharmacy and prevent late-stage complications. This global movement encourages urologists to reframe their patient conversations, using relatable metaphors and collaborative counseling to guide patients as partners in their care. By shifting focus from solely managing prostate issues to preserving bladder health, clinicians can improve outcomes while fostering a more meaningful connection with their patients.
[Dr. Jose Silva]:
Wayne, so you mentioned the resources on ManVsProstate. Any of us can go there, even can we direct patients there to the website?
[Dr. Wayne Kuang]:
Absolutely. They can go to the website, and they can log in. When you register, they'll get sent the five stages of bladder health, which is really plain spoken. I try to find that space in between too academic and too plain spoken. Then right now, we're coming out-- Last year we produced about 30 educational videos for patients that we're going to try now put out in the spring for patients to be educated about just a different approach or a different perspective for the BPH, BPO care pathway where we are prioritizing the preservation of bladder health. We are trying to put an end to the polypharmacy epidemic, and we are trying to prevent late stage BPH. That should be coming out. Then also we have an educational series for physicians as well and urologists. That'll be fun.
[Dr. Jose Silva]:
Oh, great. Wayne, anything else you want to add? I think we covered everything that you're doing. Definitely it's been years in the process, and I think it's great you're putting the word out, trying to, for us as physicians or urologists, change the way we talk to patients, change the way we approach this disease. I think it's incredible what you're doing. I think everybody should start thinking about bladder health instead of just the prostate.
[Dr. Wayne Kuang]:
Absolutely. I think if we do that-- I'll end with this. The world is dark right now. There are so many shadows now. It is rare that we as a tribe of Defenders of the Detrusor could use our cystoscopic swords and our pressure flow shields to fight for something that is so true. It is the light, a little bit of light, but it's so rare nowadays. It's for us to find something where everyone wins, patient, doc, the practice, the healthcare industry, healthcare systems. It can be a win for all. I think it's a real-- It's an experiment. As you know-- you may or not. During the pandemic, I wanted to learn how to face my own fear with playing music, so I started playing on the streets.
What it is really an adventure in sharing, giving, and receiving energy. Every time I get surprised by the ManVsProstate, is as we put out this energy, we receive it. It will disperse in a positive ripple effect that can affect positive change with our personal, professional, community, and global relationships. I ask everyone, I was just recently in Buenos Aires at Malba, the fine art museum there. They had an exhibit on habiting and transforming. To inhabit is such a word that we don't use that much. How do we inhabit our spaces? Really feel it, sit in it, breathe in it, touch it, smell it, and then transform it in a positive way and watch that positive ripple effect.
I think we can do that. I think it's a great social experiment. What can happen globally? How did the Italian Brigade start? How did the Scandinavian Brigade start? The Colombian Brigade now. Nephrologists there and general surgeons are catching on. They're not even urologists. That's fun. We need something like that. A little bit of light that we can hold in our hands and then share with others. Just a small thought, how do we inhabit and transform our space in a positive way?
[Dr. Jose Silva]:
I'm glad you're doing it. Every time I go to LinkedIn, I see your messages. They're definitely very motivating. I like being part of this movement that you have created. Like you mentioned, it's great expressing the change to the patient. That knowledge, having the patients change their mind. It's not about the prostate only, it's just preserving bladder health.
[Dr. Wayne Kuang]:
More so, it's about just guiding them and being their partner on their journey. Our goal is to let them be the hero in their own story, their own adventure, where they saved their own bladder from the villainous prostate. We're just there to be their guide.
Podcast Contributors
Dr. Wayne Kuang
Dr. Wayne Kuang is a men's health urologist in Albuquerque, New Mexico, CEO of MD for Men, and the founder of the ManVsProstate Crusade.
Dr. Jose Silva
Dr. Jose Silva is a board certified urologist practicing in Central Florida.
Cite This Podcast
BackTable, LLC (Producer). (2024, January 23). Ep. 148 – Defending the Detrusor: A Clinician’s Perspective [Audio podcast]. Retrieved from https://www.backtable.com
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.